# Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis

> **NCT05840913** · PHASE2 · COMPLETED · sponsor: **Armed Forces Institute of Dentistry, Pakistan** · enrollment: 78 (actual)

## Conditions studied

- Drug Effect
- Pulpitis - Irreversible

## Interventions

- **DRUG:** Articaine HCl 4 % / EPINEPHrine 1:100,000 in 1.8 mL Dental Cartridge

## Key facts

- **NCT ID:** NCT05840913
- **Lead sponsor:** Armed Forces Institute of Dentistry, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840913, "Different Volumes of Articaine for Inferior Alveolar Nerve Block in Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05840913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*